| # | Drug | Count |
|---|---|---|
| 0 | CONJUGATED ESTROGENS | 16 |
| 1 | ESTROGENS, CONJUGATED | 16 |
| 2 | PACLITAXEL | 16 |
| 3 | CARBOPLATIN | 15 |
| 4 | MEDROXYPROGESTERONE ACETATE | 10 |
| 5 | DENOSUMAB | 9 |
| 6 | BEVACIZUMAB | 8 |
| 7 | EVEROLIMUS | 8 |
| 8 | IBUPROFEN | 8 |
| 9 | METHOTREXATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 1 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| 2 | BACTERIOSTATIC WATER | 1 | 0.0024 |
| 3 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0015 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| 5 | PROCHLORPERAZINE EDISYLATE | 1 | 0.0008 |
| 6 | ERDAFITINIB | 1 | 0.0008 |
| 7 | METRELEPTIN | 1 | 0.0008 |
| 8 | MEGESTROL ACETATE | 2 | 0.0005 |
| 9 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 18 |
| 1 | Microtubule Inhibitor [EPC] | 16 |
| 2 | Platinum-based Drug [EPC] | 16 |
| 3 | Kinase Inhibitor [EPC] | 14 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 6 | Aromatase Inhibitor [EPC] | 9 |
| 7 | RANK Ligand Inhibitor [EPC] | 9 |
| 8 | Corticosteroid [EPC] | 8 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Leptin Analog [EPC] | 1 | 0.0008 |
| 2 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 3 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 | 0.0001 |
| 5 | Progesterone [EPC] | 3 | 0.0001 |
| 6 | Nuclear Export Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Microtubule Inhibitor [EPC] | 16 | 0.0001 |
| 8 | Estrogen [EPC] | 18 | 0.0001 |
| 9 | Anti-anginal [EPC] | 1 | 0.0001 |